Lisa Wehl (geb. Haddick)
PhD student
E-Mail:
Phone: 089-2180-77184
E2.001
Publications:
B. Boersma, K. Möller, L. Wehl, V. Puddinu, A. Huard, S. Fauteux-Daniel, C. Bourquin, G. Palmer, T. Bein, Inhibition of IL-1β release from macrophages targeted with necrosulfonamide-loaded porous nanoparticles, J. Control Release, 2022. [link]
L. Wehl, C.von Schirnding, M. Bayer, O. Zhuzhgova, H. Engelke, T. Bein.Mesoporous Biodegradable Magnesium Phosphate-Citrate Nanocarriers Amplify Methotrexate Anticancer Activity in HeLa Cells, Bioconjugate Chem, 2022 [link]
C. von Schirnding, I. Giopanou, A. Hermawan, L. Wehl, G. Ntaliarda, B. Illes, S. Datz, F. Geisslinger, K. Bartel, A.-K. Sommer, M. Lianou, V. Weiss, J. Feckl, A. M. Vollmar, C. Braeuchle, G. T. Stathopoulos, E. Wagner, A. Roidl, T. Bein, H. Engelke, Synergistic Combination of Calcium and Citrate in Mesoporous Nanoparticles Targets Pleural Tumors, Chem, 2021. [link]
L. Haddick, W. Zhang, S. Reinhard, K. Moeller, H. Engelke, E. Wagner, T. Bein, Particle-Size-Dependent Delivery of Antitumoral miRNA Using Targeted Mesoporous Silica Nanoparticles, Pharmaceutics, 2020. [link]
H.-Y. Chiu, D. Goessl, L. Haddick, H. Engelke, T. Bein, Clickable Multifunctional Large-Pore Mesoporous Silica Nanoparticles as Nanocarriers, Chem. Mater., 2018. [link]